BMRN
BioMarin Pharmaceutical Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +6.3% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 137 | +4 | 146.98M | $8.41B | +11 | −6 |
| Q1 2026 | 135 | -4 | 142.18M | $8.03B | +5 | −10 |
| Q4 2025 | 138 | +3 | 154.93M | $9.20B | +4 | — |
| Q3 2025 | 23 | -1 | 108.93M | $5.90B | — | −2 |
| Q2 2025 | 22 | -2 | 113.78M | $6.25B | — | −2 |
| Q1 2025 | 21 | 0 | 70.58M | $4.99B | +1 | −1 |
| Q4 2024 | 21 | +1 | 67.83M | $4.46B | +1 | — |
| Q3 2024 | 19 | 0 | 57.19M | $4.02B | +2 | −2 |
| Q2 2024 | 19 | — | 53.80M | $4.43B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 18.87M | +0.4% | $1.33B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Dodge & Cox ✦ | 13.90M | -0.2% | $976.91M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 3 | Viking Global Investors ✦ | 9.75M | +38.1% | $685.56M | 2.5% | ▲ Add | 2 | SEC ↗ |
| 4 | Norges Bank ✦ (passiv) | 3.53M | -2.4% | $248.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Elliott Investment Management ✦ | 3.50M | 0.0% | $246.04M | 2.4% | Held | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 3.26M | +1.9% | $228.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 3.26M | +1.9% | $228.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.20M | +115.9% | $84.66M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.20M | +115.9% | $84.66M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 663.55K | -32.5% | $46.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 663.55K | -32.5% | $46.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 642.68K | -42.5% | $45.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 598.50K | +980.9% | $42.07M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 598.50K | +980.9% | $42.07M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 598.50K | +980.9% | $42.07M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 598.50K | +980.9% | $42.07M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 418.87K | +260.5% | $29.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 299.53K | -12.0% | $21.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 197.72K | Neu | $13.90M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 163.35K | -39.1% | $11.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 163.35K | -39.1% | $11.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 142.31K | +306.8% | $10.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 23.39K | Neu | $1.64M | 0.0% | New | 1 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 13.55K | +0.9% | $952,148 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Wellington Management ✦ | 7.06K | +2.0% | $496,177 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 7.06K | +2.0% | $496,177 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | GAMCO Investors ✦ | 6.57K | +23.5% | $461,454 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $13.90M | 0.0% |
| Gotham Asset Management | $1.64M | 0.0% |
Ausgestiegen
| Soros Fund Management | $12.85M | war 0.4% |
| Marshall Wace | $3.52M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 549 Inhaber, 183.01M Anteile, $10.09B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.